跳至主要内容
临床试验/PACTR202203635372753
PACTR202203635372753招募中4 期

Primary EUS-guided biliary drainage Versus ERCP biliary drainage in distal malignant biliary obstruction

Theodr Bilharz Research institute0 个研究点目标入组 66 人开始时间: 2022年2月13日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients older than 18 years and diagnosed with malignant obstruction of the distal bile duct.
  • Type of malignancy:
  • ?Primary pancreatic cancer.
  • ?Ampulla of vater carcinoma.
  • ?Distal cholangiocarcinoma.
  • ?Pancreatic neuroendocrine tumor.
  • ?Metastatic lymph nodes.
  • ?Resectable and unresectable tumors will be included.
  • ?Patients with duodenal tumor invasion will be included.
  • Patients with performance A will be included.

排除标准

  • Patients with impaired coagulation profile.
  • Patients with sepsis (according to the severity of sepsis index).
  • Low performance.
  • Life expectancy less than 1 month.

研究者

发起方
Theodr Bilharz Research institute

相似试验